McKesson Corporation's share price trades at high nominal dollar levels due to its dominant market position as a premier global healthcare services and pharmaceutical distribution leader, robust multi-billion-dollar annual revenues, and disciplined capital allocation strategies. The company frequently engages in share repurchase programs that reduce overall share counts while maintaining steady earnings growth, reliable cash flow generation, and strong institutional backing.